The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.
May 9th 2024
A high burden of HIV could indicate other underlying factors, such as limited access to health care resources and a risk of major depressive disorder.
Increasing Access to Antiretroviral Therapies as a Global HIV/AIDS Prevention Strategy
October 1st 2016Demonstrating the efficacy of antiretroviral therapies and other treatments in preventing the spread of HIV, Thomas Quinn, MD, showed that there is hope for decreasing HIV transmissions across the world. He cautioned, however, that HIV/AIDS still remains a global pandemic, and more work must be done to accelerate the rate of decrease in HIV infections.
Read More
What We're Reading: Policies Needed to Support Prisoner Health After Release
July 15th 2016What We’re Reading, July 15, 2016: What can the 7 remaining co-ops do to survive; CMS projects increased Medicare spending per enrollee by 2025; and experts call for policy changes to support the health of prisoners at high risk for HIV.
Read More
What We're Reading: VA Failed Veterans With Brain Trauma
July 13th 2016What We’re Reading, July 13, 2016: Humira faces competition from a biosimilar; Washington, DC, campaigns to raise awareness on anti-HIV PrEP pills; and veterans may have been incorrectly diagnosed for traumatic brain injury...or not.
Read More
Special Issue of AJMC Examines Policy Questions Surrounding Hepatitis C Treatment
May 6th 2016The arrival of direct-acting antivirals to treat hepatitis C virus raised unprecedented policy questions in healthcare. This new drug class was initially met with alarm over cost and barriers to the cure, despite the potential for long-term savings, and represents one of a number of topics explored in a special issue of The American Journal of Managed Care.
Read More
Deaths From Hepatitis C Virus Hit All-Time High, CDC Reports
May 4th 2016CDC also published a separate study that found more people in the United States now die from hepatitis C than die from HIV or any other infectious disease. The report comes as The American Journal of Managed Care publishes a special issue on policy concerns over patient access to new therapies that cure HCV.
Read More
Improving HCV Cure Rates in HIV-Coinfected Patients - A Real-World Perspective
The authors examine real-world hepatitis C virus cure rates with direct-acting antivirals among patients coinfected with HIV.
Read More
Single- Versus Multiple-Tablet HIV Regimens: Adherence and Hospitalization Risk
Single-tablet regimens are associated with higher adherence rates, decreased hospitalizations, and a higher proportion of patients with undetectable viral load compared with multiple-tablet regimens in patients with HIV/AIDS.
Read More
What We're Reading: Sanders Proposes HIV/AIDS Drug Development Prize Fund
March 15th 2016What we're reading, March 15, 2016: Bernie Sanders proposes a prize fund to spur drug development for HIV/AIDS; one news outlet is going to court to unseal documents related to OxyContin's marketing; and report highlights the emotional trauma healthcare providers face after making a serious medical error.
Read More
On World AIDS Day, the Evidence for Prevention With Anti-Retroviral Therapy Is Powerful
December 1st 2015Anthony S. Fauci, MD, of the National Institute of Allergy and Infectious Disease, co-authors an article that calls for broader use of ART to bring about the end of AIDS, more than 30 years after the dawn of the pandemic.
Read More
Kaiser Poll Finds Strong Support to Control Drug Prices
April 21st 2015The Kaiser Health Tracking Poll found Americans strongly support ensuring that those with chronic conditions like cancer, HIV, and mental illness can have access to affordable drugs, and this sentiment was shared across partisan lines.
Read More
Delayed HCV Treatment in Coinfected Patients Can Prove Fatal
March 2nd 2015Modeling data discussed at a press conference at the 2015 Conference on Retroviruses and Opportunistic Infections showed that delaying HCV treatment, consequent to the high cost of the newer antiviral regimens, could prove fatal in patients coninfected with HIV.
Read More
Insurers Find New Way to Discriminate Against Patients
January 31st 2015Although one of the central features of the Affordable Care Act was eliminating discrimination based on preexisting conditions, there is evidence insurers have found ways to dissuade high-cost patients from enrolling in their plans.
Read More
Aetna Faces Class Action Lawsuit Over Mail-Order Requirement for HIV Drugs
December 29th 2014The plaintiff, John Doe, alleges that not having access to a community pharmacist will limit his ability to gain counseling on potential drug interactions. United Healthcare settled a similar action earlier in 2014. Consumer groups have also alleged discrimination against HIV patients by insurers over drug access in Florida.
Read More
On World AIDS Day, Advocates Mark "Tipping Point" Amid Complaints About Drug Prices in US
December 1st 2014On World AIDS Day, advocates mark "the beginning of the end" of the pandemic. In the United States, 2014 has been marked by battles between patient advocacy groups and some payers over the price of generic HIV drugs on exchanges under the Affordable Care Act.
Read More